Skip to main content
. 2017 Mar 30;8(26):41921–41931. doi: 10.18632/oncotarget.16707

Figure 1. Overexpression of miR-106b in HCC.

Figure 1

(A) Tumor tissues and the adjacent normal tissues were obtained from HCC patients. QRT-PCR experiments were performed to analyze the expression of miR-106b in these samples. *P < 0.05 vs. adjacent normal tissues. (B) QRT-PCR experiments were performed to analyze the expression of miR-106b in LO2, Huh7 and HepG2. *P < 0.05 vs. LO2.